Walleye Capital LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 170 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$326,700
-86.5%
13,200
-84.6%
0.00%
-97.8%
Q3 2022$2,422,000
+19.3%
85,629
+101.5%
0.05%
-65.2%
Q4 2019$2,030,000
-40.3%
42,500
-59.5%
0.13%
-34.7%
Q3 2019$3,399,000
+24.8%
104,900
+92.1%
0.20%
-32.4%
Q2 2019$2,723,000
+107.5%
54,600
+180.7%
0.30%
+38.4%
Q1 2019$1,312,00019,4540.22%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 3,057,869$86,477,0002.23%
Eagle Health Investments LP 329,713$9,324,0002.14%
Bellevue Group AG 4,058,792$114,783,0001.65%
SUVRETTA CAPITAL MANAGEMENT, LLC 959,214$27,127,0001.13%
ARMISTICE CAPITAL, LLC 1,924,000$54,411,0000.94%
Integral Health Asset Management, LLC 100,000$2,828,0000.55%
Monarch Partners Asset Management LLC 57,820$1,635,0000.49%
ArrowMark Colorado Holdings LLC 1,380,389$39,037,0000.48%
AlphaCentric Advisors LLC 15,000$424,0000.44%
PDT Partners, LLC 72,778$2,058,0000.31%
View complete list of AGIOS PHARMACEUTICALS INC shareholders